EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer

Malik H Qaddoori, Hanady S Al-Shmgani iD

International Journal of Breast Cancer · 16.02.2023 · 2023 · 1-14

DOI: 10.1155/2023/3251211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Breast Cancer, erschienen am 16.02.2023. Verfasst von Malik H Qaddoori und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Education for Pure Sciences (Ibn Al-Haitham), University of Baghdad, Baghdad, Iraq. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is important for tissue during normal physiological processes as well as in a number of diseases, including cancer. Drug resistance is one of the largest difficulties to antiangiogenesis therapy. Due to their lower cytotoxicity and stronger pharmacological advantage, phytochemical anticancer medications have a number of advantages over chemical chemotherapeutic drugs. In the current study, the effectiveness of AuNPs, AuNPs-GAL, and free galangin as an antiangiogenesis agent was evaluated. Different physicochemical and molecular approaches have been used including the characterization, cytotoxicity, scratch wound healing assay, and gene expression of VEGF and ERKI in MCF-7 and MDA-MB-231 human breast cancer cell line. Results obtained from MTT assay show cell growth reduction in a time- and dose-dependent aspect; also, in comparison to individual treatment, a synergistic impact was indicated. CAM assay results demonstrated galangin-gold nanoparticle capacity to suppress angiogenesis in chick embryo. Additionally, altering VEGF and ERKI gene expression was recorded. Taken together, all the results can conclude that galangin-conjugated gold nanoparticles can be a promising antiangiogenesis supplemental drug in breast cancer treatment.

Autor:innen und Institutionen

  • Department of Biology, College of Education for Pure Sciences (Ibn Al-Haitham), University of Baghdad, Baghdad, Iraq.

ORCID-Profile: Hanady S Al-Shmgani

Zitieren

APA

Qaddoori, M. H., & Al-Shmgani, H. S. (2023). Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer. International Journal of Breast Cancer, 2023, 1-14. https://doi.org/10.1155/2023/3251211

Vancouver

Qaddoori MH, Al-Shmgani HS. Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer. International Journal of Breast Cancer. 2023;2023:1-14. doi:10.1155/2023/3251211

BibTeX
@article{Qaddoori2023,
  author = {Qaddoori, Malik H and Al-Shmgani, Hanady S},
  title = {Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer},
  journal = {International Journal of Breast Cancer},
  year = {2023},
  volume = {2023},
  pages = {1--14},
  doi = {10.1155/2023/3251211}
}
Kostenlos starten →